(SPAC) Acquisition investigation for special purposes: KIND, OPFI, OTMO, …

(SPAC) Acquisition investigation for special purposes: KIND, OPFI, OTMO, …

Facebook
Twitter
LinkedIn

SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) — Shareholder law firm Johnson Fistel, LLP is investigating possible violations of law related to the following special purpose entities (“SPACs”): Nextdoor Holdings, Inc. w/k/a Khosla Ventures Acquisition Co. II KIND, OppFi Inc. w/k/a FG New America Acquisition Corporation OPFI, Otonomo Technologies Ltd. w/k/a Software Acquisition Group Inc. II OTMOand Pardes Biosciences, Inc. w/k/a FS Development Corp PRDS.

If you are an investor who has suffered losses related to any of the SPACs purchased below: Click or paste the following web address into your browser to submit your losses:

Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II KIND: https://www.johnsonfistel.com/investigations/nextdoor-holdings-inc-khosla-ventures

OppFi Inc. f/k/a FG New America Acquisition Corporation OPFI: https://www.johnsonfistel.com/investigations/oppfi-inc-fka-fg-new-america-acquisition

Otonomo Technologies Ltd. w/k/a Software Acquisition Group Inc. II OTMO: https://www.johnsonfistel.com/investigations/otonomo-technologies-software-acquisition

Pardes Biosciences, Inc. f/k/a FS Development Corp PRDS: https://www.johnsonfistel.com/investigations/pardes-biosciences-inc-fs-development

Or contact Jim Baker at for more information jimb@johnsonfistula.com or (619) 814-4471

About Johnson Fistula, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in class action lawsuits involving shareholder derivatives and securities. Johnson Fistula seeks to recover losses incurred as a result of violations of federal securities laws. For more information about the firm and its attorneys, visit http://www.johnsonfistula.com. attorney advertising. Past results do not guarantee future results.

Contact:
Johnson Fistula, LLP
jim baker, 619-814-4471
Investor Relations
jimb@johnsonfistula.com


[ad_2]

Source story

More to explorer